South & Central America Transfection Reagents and Equipment Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)


No. of Pages: 108    |    Report Code: BMIRE00030566    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Transfection Reagents and Equipment Market

The South & Central America transfection reagents and equipment market was valued at US$ 55.80 million in 2022 and is expected to reach US$ 99.22 million by 2030; it is estimated to register at a CAGR of 7.5% from 2022 to 2030.

Growing Economic Burden of Cancer Fuels South & Central America Transfection Reagents and Equipment Market



According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, and it accounted for ~10 million deaths in 2020. As per the International Agency for Research on Cancer, the global cancer burden is likely to increase with the addition of 30.2 million more cases by 2040. According to the Breast Cancer Organization, approximately 5-10% of breast cancer cases worldwide are hereditary and are caused by abnormal genes passed from generations. According to the article "Lifestyle, Genetic Risk and Incidence of Cancer," published in the International Journal of Epidemiology in 2023, nearly 33% of cancer conditions that occur are hereditary, and the risk of genetic mutations is high in the disease. Hence, people are opting for genetic profiling for the early detection and personalized treatment of hereditary cancer cases. BRCA1 and BRCA2 are sometimes referred to as tumor suppressor genes. People who inherit the harmful variants of one of these genes are at a greater risk of several cancers, most notably breast and ovarian cancer, among other types. These people also tend to develop cancer at younger ages compared to people who do not have variations in the said genes. Studies focused on nucleic acid processing by cancer cells are likely to help understand cancer metabolism. DNA is typically packaged into a viral or non-viral particle to be transferred into the cell that is to be transfected. Gene transfer has been proposed as a new approach to enhance the effectiveness of antitumor drugs in treating intractable or metastatic cancers. The association of gene therapy and drugs (similar therapy) has been reported to strengthen the antiproliferative effects of classical treatments in lung, colorectal, pancreatic, bladder, and breast cancers, among others. Thus, the elevating economic burden of cancer bolsters the South & Central America transfection reagents and equipment market.

South & Central America Transfection Reagents and Equipment Market Overview



South and Central America region is segmented into Brazil, Argentina, and Rest of South & Central America. Brazil hold more than half of the regional share in the year 2022.

Brazil has made significant developments in the pharmaceutical industry owing to its favorable economic policies and reforms, a solid hold in domestic pharmaceutical production, and elevated healthcare expenditure. As per the International Trade Administration (ITA), Brazil is the largest healthcare market in Latin America, and it spends 9.1% of its GDP on healthcare. Domestic companies dominate the total production of pharmaceutical products in the country, enabling its trade activities. As per the US Department of Commerce, domestic companies account for ~80% of the total count of pharmaceutical companies in Brazil. Thus, the growing pharmaceutical industry landscape is one of the major factors for Transfection reagents and equipment market growth in Brazil.

Furthermore, Argentina has the largest pharmaceutical industry in South & Central America, after Brazil. The transfection reagents and equipment market growth in the country is widely driven by extensive research and development efforts and growing domestic production of pharmaceuticals. The growing demand for pharmaceutical and biopharmaceutical products due to increasing uncertainties of health conditions, increasingly powerful regulatory environment for the pharmaceutical industry, and improving logistics of raw materials are likely to favor the growth of the transfection reagents and equipment market in Argentina during the forecast period.

South & Central America Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)


South & Central America Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)
Get more information on this report

South & Central America Transfection Reagents and Equipment Strategic Insights

Strategic insights for the South & Central America Transfection Reagents and Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/south-and-central-america-transfection-reagents-and-equipment-market-strategic-framework.webp
Get more information on this report

South & Central America Transfection Reagents and Equipment Report Scope

Report Attribute Details
Market size in 2022 US$ 55.80 Million
Market Size by 2030 US$ 99.22 Million
Global CAGR (2022 - 2030) 7.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Product
  • Reagents and Instruments
By Method
  • Viral Methods
  • Non Viral Methods
  • Hybrid Methods
By End User
  • Academics & Research Institutes and Pharmaceutical & Biotechnology Companies
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Get more information on this report

    South & Central America Transfection Reagents and Equipment Regional Insights

    The geographic scope of the South & Central America Transfection Reagents and Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/south-and-central-america-transfection-reagents-and-equipment-market-geography.webp
    Get more information on this report

    South & Central America Transfection Reagents and Equipment Market Segmentation



    The South & Central America transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

    Based on product, the South & Central America transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

    In terms of method, the South & Central America transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

    By application, the South & Central America transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

    Based on end user, the South & Central America transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

    Based on country, the South & Central America transfection reagents and equipment market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America transfection reagents and equipment market in 2022.

    Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the South & Central America transfection reagents and equipment market.

    The List of Companies - South & Central America Transfection Reagents and Equipment Market

    1. Thermo Fisher Scientific Inc
    2. Promega Corp
    3. F. Hoffmann-La Roche Ltd
    4. Bio-Rad Laboratories Inc
    5. Mirus Bio LLC
    6. QIAGEN NV
    7. Merck KGaA
    8. Lonza Group AG
    9. MaxCyte Inc

    Frequently Asked Questions
    How big is the South & Central America Transfection Reagents and Equipment Market?

    The South & Central America Transfection Reagents and Equipment Market is valued at US$ 55.80 Million in 2022, it is projected to reach US$ 99.22 Million by 2030.

    What is the CAGR for South & Central America Transfection Reagents and Equipment Market by (2022 - 2030)?

    As per our report South & Central America Transfection Reagents and Equipment Market, the market size is valued at US$ 55.80 Million in 2022, projecting it to reach US$ 99.22 Million by 2030. This translates to a CAGR of approximately 7.5% during the forecast period.

    What segments are covered in this report?

    The South & Central America Transfection Reagents and Equipment Market report typically cover these key segments-

  • Product (Reagents and Instruments)
  • Method (Viral Methods, Non Viral Methods, Hybrid Methods)
  • End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)
  • What is the historic period, base year, and forecast period taken for South & Central America Transfection Reagents and Equipment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Transfection Reagents and Equipment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in South & Central America Transfection Reagents and Equipment Market?

    The South & Central America Transfection Reagents and Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Who should buy this report?

    The South & Central America Transfection Reagents and Equipment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Transfection Reagents and Equipment Market value chain can benefit from the information contained in a comprehensive market report.